Norway· NO-ID_1C5A1FA1-3AE2-4979-B0D6-4FC1D5BB2C47

Fendrix

A hepatitis b, gereinigtes antigen product containing aluminium phosphate, hepatitis b surface antigen (rdna) adjuvanted by as04c adsorbed on aluminium phosphate [produced in s. cerevisiae by rdna], 3-o-desacyl-4'-monophosphoryl lipid a, registered in Norway by GlaxoSmithKline. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedFendrixATCJ07BC01REGISTER NO.NO-ID_1C5A1FA1-3AE2-4…PACKS LISTED3CHECKEDOctober 2, 2026

Where it is registered

Hepatitis b, gereinigtes antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC01 (hepatitis b, gereinigtes antigen), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Hepatitis b, gereinigtes antigen · ATC J07BC01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Aluminium Phosphate, Hepatitis B Surface Antigen (Rdna) Adjuvanted By As04c Adsorbed On Aluminium Phosphate [produced In S. Cerevisiae By Rdna], 3-O-Desacyl-4'-Monophosphoryl Lipid A
Manufacturer
GlaxoSmithKline
Country
Norway (NO)
ATC code
J07BC01
ATC class
Hepatitis B, gereinigtes Antigen
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_1C5A1FA1-3AE2-4979-B0D6-4FC1D5BB2C47
  • no_varenummer
    016785
    0.5
    NOK 502
  • gtin
    5050459000309

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

255 interactions on record for hepatitis b, gereinigtes antigen.

Graded by severity as the source publishes them — 255 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Hepatitis b, gereinigtes antigen · interactions on record

255 records

  • 255 moderate

Most severe, free to view

  • PrednisoloneA07EA01moderate
  • HydrocortisoneA07EA02moderate
  • PrednisoneA07EA03moderate
  • BetamethasoneA07EA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/54e681e6-1e4f-4d61-8a18-6bf94dcf4cb7
GET /v1/drugs/54e681e6-1e4f-4d61-8a18-6bf94dcf4cb7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, suspensjon",
  "source": "fest",
  "status": "A",
  "atc_name": "Hepatitt B, renset antigen",
  "merkevare_id": "ID_1C5A1FA1-3AE2-4979-B0D6-4FC1D5BB2C47",
  "name_form_strength": "Fendrix inj væske, susp 20 mikrog/sprøyte",
  "prescription_group": "C"
}

See everything about hepatitis b, gereinigtes antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.